Field Trip Health Begins Trading on TSE, Sets Sights on Nasdaq
Business
Psychedelic lifestyle brand Field Trip Health is now trading on the Toronto Stock Exchange under the symbol "FTRP".
Another psychedelic company readies for Nasdaq.
The Peter Thiel-backed psychedelic biopharmaceutical company Atai Life Sciences has announced plans to IPO with a launch on Nasdaq under the symbol “ATAI.” The IPO, valued at more than $2 billion, is expected to launch with more than 14 million common shares, with a 30-day option for underwriters to purchase an additional 2.1 million shares. It should raise more than $214 million. Credit Suisse, Citigroup, Cowen, and Berenberg led the underwriters for the offering.
The Berlin-based startup is one of a number of life sciences companies working with psychedelics to treat mental health conditions including depression, anxiety, and substance abuse disorders. The company, which was founded by Christian Angermayer, Florian Brand, Lars Wilde, and Srinivas Rao, launched in 2018. The aim was to tackle a lack of innovation in mental health treatment.
Atai has raised more than $157 million to date, including $12 million from the billionaire PayPal co-founder last November.
“ATAI’s great virtue is to take mental illness as seriously as we should have been taking all illness all along,” Thiel said last year. “The company’s most valuable asset is its sense of urgency.”
With ten development programs and six enabling technologies in its current portfolio, Atai is now also conducting Phase 2 trials with one of its companies, Recognify Life Sciences. It's also expecting to launch more Phase 2 trials in 2022 to further explore the benefits of psychedelics in mental health treatment.
Join us for our launch event on July 18th, where we’ll share about the work we’ll be doing together to actualize our personal missions, grow, and heal together.
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.